Enliven Therapeutics (ELVN) Ownership - Who Owns Enliven Therapeutics?

331 Followers

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 10, 2026	Benjamin Hohl	xxxxxxxxxxxxx	$295800

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Baker Bros Advisors Lp	xxxxxxxxxxxxx	$4179652
Dec 31, 2025	Woodline Partners Lp	xxxxxxxxxxxxx	$4635754
Dec 31, 2025	Blackstone Inc.	xxxxxxxxxxxxx	$14706168

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	7,663,349	Insider	12.81%	297,567,842
Peter Harwin	3,711,444	Institution	6.21%	144,115,371
	2,404,745	Institution	4.02%	93,376,248
	2,281,261	Institution	3.81%	88,581,365
	2,134,061	Institution	3.57%	82,865,589
	2,068,511	Institution	3.46%	80,320,282
	1,552,567	Institution	2.60%	60,286,177
	1,166,077	Institution	1.95%	45,278,770
	1,144,262	Institution	1.91%	44,431,693
Stephen A. Schwarzman	954,946	Institution	1.60%	37,080,553

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
2,281,261	Institution	3.81%	88,581,365
2,068,511	Institution	3.46%	80,320,282
1,552,567	Institution	2.60%	60,286,177
1,166,077	Institution	1.95%	45,278,770
1,144,262	Institution	1.91%	44,431,693
712,291	Institution	1.19%	27,658,260
555,781	Institution	0.93%	21,580,976
416,922	Institution	0.70%	16,189,081
338,800	Institution	0.57%	13,155,604
245,903	Institution	0.41%	9,548,413

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	1,584,797	Institution	2.65%	47,052,623
iShares Russell 2000 ETF	945,199	Institution	1.58%	36,702,077
Vanguard Extended Market ETF	487,085	Institution	0.81%	14,461,554
iShares Biotechnology ETF	323,561	Institution	0.54%	12,563,874
iShares Russell 2000 Growth ETF	320,511	Institution	0.54%	12,445,442
Schwab U.S. Small-Cap ETF	215,037	Institution	0.36%	8,448,804
Vanguard Russell 2000 ETF	195,031	Institution	0.33%	5,790,470
SPDR S&P Pharmaceuticals ETF	193,985	Institution	0.32%	7,621,671
Dimensional U.S. Small Cap ETF	176,387	Institution	0.29%	6,930,245
iShares U.S. Pharmaceuticals ETF	123,867	Institution	0.21%	4,809,756

FAQ

Who Owns Enliven Therapeutics (ELVN)?

Currently, no data Available

What percentage of Enliven Therapeutics (ELVN) stock is held by institutional investors?

Currently, no data Available

What percentage of Enliven Therapeutics (ELVN) stock is held by retail investors?

Currently, no data Available

Who owns the most shares of Enliven Therapeutics (ELVN)?

Rishi Gupta owns the most shares of Enliven Therapeutics (ELVN).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.